Product Information
ALPRAZOLAM ER 3 MG TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.3238 per EA under NDC 00228308606. Its NADAC has been published 662 times since Nov 28, 2013.
FDA first approved this application on Feb 13, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
Actavis Pharma, Inc.NDC
00228308606
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
7/22/2026
Active Ingredients
ALPRAZOLAMApproval Type
Generic (ANDA)
FDA Application
ANDA078056FDA Approved
2/13/2007
TE Code
AB
On Market Since
3/12/2007
Pharmacological Classes
Price Statistics
The NADAC for ALPRAZOLAM ER 3 MG TABLET has been published 662 times since Nov 28, 2013, and over the history we have for it it has declined 44.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3238 per EA |
|---|---|
| All-time high | $0.9784 (Aug 10, 2016) |
| All-time low | $0.1851 (Jan 22, 2025) |
| 52-week high | $0.3886 |
| 52-week low | $0.2837 |
| Median price | $0.3532 |
| Average price | $0.4435 |
| Largest weekly change | +58.7% (May 17, 2023) |
| Weeks tracked | 662 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
0.0%
3M
-1.4%
6M
-2.9%
1Y
+14.1%
3Y
+39.2%
5Y
-17.1%
All
-44.6%
Last surveyed Jul 29, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 8% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ALPRAZOLAM ER 3 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ALPRAZOLAM ER 3 MG TABLET, manufactured by Actavis Pharma, Inc., is $0.3238 per EA (NDC 00228308606), effective Jul 29, 2026.
How has the price of ALPRAZOLAM ER 3 MG TABLET changed over time?
Over the history we have for it, the NADAC for ALPRAZOLAM ER 3 MG TABLET has declined 44.6%. It has been tracked across 662 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ALPRAZOLAM ER 3 MG TABLET?
Since Nov 28, 2013, the NADAC for ALPRAZOLAM ER 3 MG TABLET has ranged from a low of $0.1851 (Jan 22, 2025) to a high of $0.9784 (Aug 10, 2016), with a median of $0.3532 per EA.
Are there cheaper alternatives to ALPRAZOLAM ER 3 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ALPRAZOLAM ER 3 MG TABLET, is $0.2972 per EA — about 8% below ALPRAZOLAM ER 3 MG TABLET.
Who manufactures ALPRAZOLAM ER 3 MG TABLET?
ALPRAZOLAM ER 3 MG TABLET (NDC 00228308606) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.